Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Am Heart J. 2013 Apr 6;165(6):972–978. doi: 10.1016/j.ahj.2013.02.024

Table II.

Univariate Associations between HbA1c≥7% vs. <7%, Comorbid Conditions, Medications and 30-day CVD Rehospitalization

30-day CVD Rehospitalization
OR (95%CI)
Main Outcome
  HbA1c>7% vs.<7% (Overall) 1.63 (1.05–2.54)
    Female 4.83 (1.84–12.71)
    Male 1.02 (0.60–1.71)
Demographic Conditions
  Age (>65 years vs. <65 years) 1.30 (0.86–1.97)
  Race/ethnic group (minority vs. white) 1.22 (0.80–1.87)
  Gender (male vs. female) 1.22 (0.80–1.86)
  Health insurance (none or self-pay vs. insured) 1.07 (0.67–1.73)
  Caregiving (paid or informal caregiver vs. none) 1.29 (0.86–1.93)
Comorbid Conditions
  Insulin-dependent diabetes (yes vs. no) 1.21 (0.81–1.81)
  Prior/Current MI (yes vs. no) 1.32 (0.88–1.98)
  Prior/Current CHF (yes vs. no) 1.64 (1.09–2.48)
  Prior/Current stroke (yes vs. no) 0.92 (0.50–1.66)
  Prior/Current moderate to severe renal disease (yes vs. no) 1.37 (0.90–2.08)
  Prior/Current COPD (yes vs. no) 1.49 (0.76–2.95)
  Prior/Current PVD (yes vs. no) 1.06 (0.63–1.78)
  Smoking status (current vs. prior or never) 1.05 (0.51–2.19)
  Dyslipidemia history (yes vs. no) 0.90 (0.58–1.38)
  Ghali Comorbidity Index >1 (yes vs. no) 1.61 (1.05–2.46)
  Had cardiac surgery during admission (yes vs. no) 0.79 (0.43–1.46)
Prescribed medications on discharge
  Statin (yes vs. no) 1.19 (0.69–2.05)
  ACE-I/ARB (yes vs. no) 1.25 (0.83–1.88)
  Beta-blocker (yes vs. no) 0.85 (0.53–1.36)
  Antiplatelet (yes vs. no) 1.52 (0.79–2.93)
  New insulin (yes vs. no) 0.72 (0.34–1.54)